TPG Growth, the middle market and growth equity platform of alternative asset firm TPG, today announced that it made a significant minority investment in AnovoRx Holdings, Inc. (“Anovo”), a leading provider of specialty pharmacy services and customized treatment and support programs that address the unique needs of patients with certain complex and chronic diseases.
Read the full article: TPG Invests in AnovoRx //
Source: https://www.businesswire.com/news/home/20220111006139/en/TPG-Invests-in-AnovoRx